BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22091430)

  • 21. [Clinical characteristics and outcomes of lung cancer patients 
with EGFR mutations in exons 19 and 21].
    Liu R; Liu J; Li X; Li Y; Zhao Q; Li Z; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):804-11. PubMed ID: 25404271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer.
    Komurcuoglu B; Karakurt G; Kaya OO; Diniz G; Kırbıyık O; Evkan A; Yalnız E
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S183-S190. PubMed ID: 37147996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
    Ge M; Zhuang Y; Zhou X; Huang R; Liang X; Zhan Q
    J Neurooncol; 2017 Nov; 135(2):413-418. PubMed ID: 28780743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients.
    Lee SM; Bae SK; Jung SJ; Kim CK
    Clin Nucl Med; 2015 Dec; 40(12):950-8. PubMed ID: 26359571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between vascular-poor area of primary tumors and epidermal growth factor receptor gene status in advanced lung adenocarcinoma.
    Togashi Y; Masago K; Kubo T; Fujimoto D; Sakamori Y; Nagai H; Kim YH; Togashi K; Mishima M
    Med Oncol; 2012 Dec; 29(5):3169-75. PubMed ID: 22492281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.
    Wang S; Wang Z
    Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):30-9. PubMed ID: 25445553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions.
    Hung MS; Lin CK; Leu SW; Wu MY; Tsai YH; Yang CT
    Chang Gung Med J; 2006; 29(4):373-9. PubMed ID: 17051834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan.
    Guan J; Chen M; Xiao N; Li L; Zhang Y; Li Q; Yang M; Liu L; Chen L
    Med Oncol; 2016 Jan; 33(1):1. PubMed ID: 26589606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer.
    Huang HM; Wei Y; Wang JJ; Ran FY; Wen Y; Chen QH; Zhang BF
    Balkan J Med Genet; 2023 May; 25(2):29-36. PubMed ID: 37265968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: a single-institution retrospective analysis.
    Na II; Byun BH; Kim KM; Cheon GJ; Choe du H; Koh JS; Lee DY; Ryoo BY; Baek H; Lim SM; Yang SH; Kim CH; Lee JC
    Lung Cancer; 2010 Jan; 67(1):76-80. PubMed ID: 19371962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse Lung Metastases in
    Digumarthy SR; Mendoza DP; Padole A; Chen T; Peterson PG; Piotrowska Z; Sequist LV
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients.
    Bichev SN; Marinova DM; Slavova YG; Savov AS
    Cell Oncol (Dordr); 2015 Apr; 38(2):145-53. PubMed ID: 25534657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis.
    Lee DS; Kang JH; Lee CG; Kim SJ; Choi YJ; Lee KY; Kim YS
    Cancer Res Treat; 2013 Jun; 45(2):95-102. PubMed ID: 23864842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non-Small-Cell Lung Cancer.
    Bhatt VR; D'Souza SP; Smith LM; Cushman-Vokoun AM; Noronha V; Verma V; Joshi A; Chougule A; Jambhekar N; Kessinger A; Marr A; Patil V; Banavali SD; Ganti AK; Prabhash K
    J Glob Oncol; 2017 Jun; 3(3):208-217. PubMed ID: 28717762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.
    Créquit P; Ruppert AM; Rozensztajn N; Gounant V; Vieira T; Poulot V; Antoine M; Chouaid C; Wislez M; Cadranel J; Lavole A
    Lung Cancer; 2016 Jun; 96():74-7. PubMed ID: 27133754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
    Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW
    Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: an observational study.
    Schuette W; Schirmacher P; Eberhardt WE; Fischer JR; von der Schulenburg JM; Mezger J; Schumann C; Serke M; Zaun S; Dietel M; Thomas M
    Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1254-61. PubMed ID: 26070531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas.
    Woo JH; Kim TJ; Kim TS; Han J
    Sci Rep; 2020 Oct; 10(1):16251. PubMed ID: 33005033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.